Stem Cell Blog
Stem Cell Blog
What Does Research Say About Stem Cells and Scarring?
Key details Current limitations: Traditional scar treatments (such as surgery, silicone gels, corticosteroids, and laser therapy) can improve appearance and symptoms but are often only partially effective, and no gold-standard treatment exists for symptomatic...
Stem Cell Therapy for Congenital Heart Defect Begins Pivotal Trial Phase
A stem cell therapy for hypoplastic left heart syndrome (HLHS), a serious congenital heart defect that affects blood flow through the heart, has entered a key clinical trial stage. The therapy aims to strengthen the heart and improve outcomes for children with the...
Could Stem Cells Help Treat Ischaemic Stroke Consequences?
Key details Current treatment limitations: While ischaemic strokes – which account for nearly 90% of all strokes – are currently treated with clot removal and supportive rehabilitation, there remains a significant unmet need for therapies that directly address...
Umbilical Cord Stem Cell Therapy for Charcot-Marie-Tooth Disease to Begin Phase 2 Trial
Key details New trial approval: The South Korean Ministry of Food and Drug Safety has approved a Phase 2a trial for a new umbilical cord stem cell therapy to treat Charcot-Marie-Tooth disease (CMT), one of the most commonly inherited nerve diseases.[1] Early clinical...
Umbilical Cord Blood Transplant for Lesch-Nyhan Syndrome
Key details Understanding Lesch-Nyhan syndrome: This rare, recessive condition linked to the X chromosome primarily affects boys, and is characterised by a deficiency of the HPRT enzyme, leading to severe motor dysfunction, uric acid overproduction, and compulsive...
Recent Posts
-
How Long Can Stem Cells Stay Frozen? New Study Finds Cells Still Working After 13 Years
-
First US Patient Treated in Phase 3 Trial of Cord Blood Stem Cell Therapy for Knee Osteoarthritis
-
Could a Blood Test at 12 Weeks Predict Pre-eclampsia?
-
Could Sibling Cord Blood Help a Child With Cerebral Palsy?
-
Cord Tissue Stem Cell Therapy for Pulmonary Fibrosis Completes First Human Safety Trial
